About Trapelo
Trapelo is a company based in Fort Myers (United States) founded in 2009 was acquired by NeoGenomics in March 2021.. Trapelo has raised $16.23 million across 4 funding rounds from investors including NeoGenomics, Chrysalis Ventures and Beringea. Trapelo offers products and services including Trapelo Platform and Precision Medicine Podcast. Trapelo operates in a competitive market with competitors including Tempus, Personalis, CancerIQ, Perthera and LinkDoc, among others.
- Headquarter Fort Myers, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.23 M (USD)
in 4 rounds
-
Latest Funding Round
$4.16 M (USD), Series B
Nov 08, 2017
-
Investors
NeoGenomics
& 4 more
-
Employee Count
Employee Count
-
Acquired by
NeoGenomics
(Mar 24, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Trapelo
Trapelo offers a comprehensive portfolio of products and services, including Trapelo Platform and Precision Medicine Podcast. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for precision medicine testing and treatment decisions.
Podcast featuring discussions on precision medicine innovations.
Unlock access to complete
Unlock access to complete
Funding Insights of Trapelo
Trapelo has successfully raised a total of $16.23M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $4.16 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $4.2M
-
First Round
First Round
(18 Jul 2011)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2017 | Amount | Series B - Trapelo | Valuation |
investors |
|
| Dec, 2012 | Amount | Series B - Trapelo | Valuation | Chrysalis Ventures |
|
| Jul, 2011 | Amount | Series B - Trapelo | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Trapelo
Trapelo has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include NeoGenomics, Chrysalis Ventures and Beringea. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm making investment in early & growth stage healthcare & tech companies in the US
|
Founded Year | Domain | Location | |
|
Investments are made in growth-stage startups by Beringea.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Trapelo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Trapelo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Trapelo Comparisons
Competitors of Trapelo
Trapelo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tempus, Personalis, CancerIQ, Perthera and LinkDoc, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based precision medicine solutions for oncology are provided.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
CancerIQ is focused on precision cancer prevention and care.
|
|
| domain | founded_year | HQ Location |
Molecular cancer profiling is conducted via genomics and proteomics.
|
|
| domain | founded_year | HQ Location |
Oncology-focused database is provided for cancer analytics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Trapelo
Frequently Asked Questions about Trapelo
When was Trapelo founded?
Trapelo was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Where is Trapelo located?
Trapelo is headquartered in Fort Myers, United States. It is registered at Fort Myers, Florida, United States.
Is Trapelo a funded company?
Trapelo is a funded company, having raised a total of $16.23M across 4 funding rounds to date. The company's 1st funding round was a Series B of $2.27M, raised on Jul 18, 2011.
What does Trapelo do?
Trapelo was founded in 2009 and is headquartered in Fort Myers, United States. The company operates in the healthcare sector, focusing on oncology through a unified technology platform. Real-time evidence-based decision support is enabled, along with treatment selection and reimbursement assurance for oncologists. The platform is utilized by providers, payers, pathologists, and related stakeholders to facilitate precision medicine applications.
Who are the top competitors of Trapelo?
Trapelo's top competitors include Tempus, Personalis and CancerIQ.
What products or services does Trapelo offer?
Trapelo offers Trapelo Platform and Precision Medicine Podcast.
Who are Trapelo's investors?
Trapelo has 5 investors. Key investors include NeoGenomics, Chrysalis Ventures, Beringea, Hopen Life Science Ventures, and Charter Capital Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.